NW Biotherapeutic challenges cancer with DC-Vax

NYFP

by NYFP

97
243 views
  • About
  • Export
  • Add to
05/01/13 Northwest Biotherapeutic's CEO, Linda Powers, discusses the company's DCVax® technology and weighs in on regulatory challenges in the industry.

0 comments